Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $196,491 - $229,745
-2,635 Closed
0 $0
Q3 2021

Oct 28, 2021

BUY
$73.77 - $83.61 $74,950 - $84,947
1,016 Added 62.75%
2,635 $212,000
Q2 2021

Jul 27, 2021

BUY
$80.5 - $88.01 $100,625 - $110,012
1,250 Added 338.75%
1,619 $130,000
Q1 2021

Apr 27, 2021

BUY
$76.38 - $86.03 $1,909 - $2,150
25 Added 7.27%
369 $31,000
Q4 2020

Jan 26, 2021

BUY
$75.39 - $82.36 $1,055 - $1,153
14 Added 4.24%
344 $28,000
Q3 2020

Oct 29, 2020

BUY
$78.33 - $90.73 $4,621 - $5,353
59 Added 21.77%
330 $27,000
Q2 2020

Jul 29, 2020

BUY
$78.66 - $94.14 $2,359 - $2,824
30 Added 12.45%
271 $23,000
Q1 2020

Apr 22, 2020

BUY
$71.57 - $93.3 $930 - $1,212
13 Added 5.7%
241 $20,000
Q4 2019

Jan 24, 2020

BUY
$76.7 - $88.45 $306 - $353
4 Added 1.79%
228 $19,000
Q3 2019

Oct 29, 2019

BUY
$81.4 - $89.78 $4,884 - $5,386
60 Added 36.59%
224 $20,000
Q2 2019

Aug 01, 2019

BUY
$73.44 - $82.41 $3,304 - $3,708
45 Added 37.82%
164 $13,000
Q1 2019

Apr 23, 2019

BUY
$64.48 - $81.31 $5,158 - $6,504
80 Added 205.13%
119 $10,000
Q4 2018

Jan 22, 2019

BUY
$61.45 - $77.8 $2,396 - $3,034
39 New
39 $3,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Eukles Asset Management Portfolio

Follow Eukles Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.